Assets Acquisition (Tables)

12 Months Ended

Jun. 30, 2025

Assets Acquisition [Abstract]

Schedule of Fair Value of the Identifiable Assets

The following table summarizes the fair value of the identifiable assets:

	Amount
Total consideration in cash	$	552,730
Assets acquired and liabilities assumed:
Cash acquired		9
Original paid in capital paid to Hupan Pharmaceutical		276,365
Intangible assets – license of pharmaceutical distribution		418,867
Other payables		(37,794	)
Deferred tax liabilities		(104,717	)
Total assets acquired	$	552,730